Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Ibandronate manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Spain

Clear all

1 products found

ibandronate

Tablets, film coated 150 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Bonviva®
Manufacturer #252
This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

Manufacturer usually replies in 12 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Ibandronate

Ibandronate injection happens to be used for preventing and treating osteoporosis (a disease in which the bones developed thin, brittle, and break quickly) in women who have gone through menopause ('' life change; '' end of menstrual periods.). It is in a class of medications called bisphosphonates. It works by preventing the degradation of bones and increasing their density (thickness). Injectable medicine helps treat osteoporosis only as long as you give regular injections. It is important to give yourself this injection once every 3 months for as long as your doctor tells you to, but check with your doctor occasionally about whether you still need to take this injection.

How does Ibandronate Work?

It is used for treating or preventing osteoporosis (soft and brittle bones) in women who have reached menopause. This medication might be provided to you for a variety of reasons. Consult your physician. It is a prescription drug used to treat or prevent bone loss in postmenopausal women, often known as osteoporosis. Bisphosphonates are a class of medicines that delay the breakdown of bone. Oral: Ibandronate is an osteoporosis medication that is prescribed to treat or prevent the disease (thinning of bones and increased risk of bones breaking). It is prescribed to women who have reached menopause (the end of menstrual periods). This medicine might be administered for a variety of reasons. For further information, see your doctor or pharmacist. Injectable: Ibandronate is an osteoporosis medication that is prescribed to treat or prevent the disease (thinning of bones and increased risk of bones breaking). This medicine might be administered for a variety of reasons. For further information, see your doctor or pharmacist. Bisphosphonates work by inhibiting bone resorption and turnover activity in bone cells (osteoclasts), reducing progressive bone loss and fracture risk.

Price of Ibandronate

Depending on the drugstore you visit, ibandronate oral tablet 150 mg costs approximately $47 for a supply of three pills. Prices are only applicable for cash paying clients and do not apply to insurance policies.

Supplying Ibandronate Manufacturers and Suppliers

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Ibandronate offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturers and this substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Ibandronate. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Ibandronate is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over this medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are on-boarded on the platform. This allows us to screen Ibandronate manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation